Treating Irritable Bowel Syndrome with constipation may have a significant impact on absenteeism

	Tweet

A new study shows that treating Irritable bowel syndrome (IBS) with constipation may have a significant impact on absenteeism from work, as well as improving presenteeism - defined as coming to work but being less productive.

Canadian researchers from The University of Alberta and Novartis Pharmaceuticals Canada presented findings of a study of tegaserod in patients with Irritable bowel syndrome characterized by constipation at the 70th Annual Scientific Meeting of the American College of Gastroenterology.

”Irritable bowel syndrome symptoms of Abdominal pain or discomfort, bloating and constipation are associated with impaired quality of life and are the second most common cause of work-related absenteeism,” according to Dr. Nigel Flook of the University of Alberta.

The study was conducted in a routine clinical practice setting with patients from 481 community physician sites across Canada. Researchers analyzed baseline data and survey responses at four and twelve weeks from 483 patients. They found that treatment with tegaserod was associated with a decrease in self-reported absenteeism in patients with symptoms of Abdominal pain/discomfort, bloating and constipation: 27 percent of patients reported improvement in the number of days per month missed at school or work. Significant findings included improvements among approximately 50 percent of patients in the number of days per month when they accomplished less at school, work or home; while about 40 percent reported improvements in the number of days per month they had to cancel or reschedule activities because of their symptoms.

Irritable bowel syndrome is a functional gastrointestinal (GI) disorder characterized by recurring symptoms of abdominal discomfort or pain associated with an altered bowel habit, either constipation, diarrhea, or both. More than 58 million people suffer from Irritable bowel syndrome, which affects more women (80%) than men. Irritable bowel syndrome is a real medical condition, but it is not life threatening, and will not lead to other serious diseases. In Irritable bowel syndrome, the GI tract may function differently, processing more slowly (or more quickly) than the average person. While the cause of this different “pace” of the GI tract in Irritable bowel syndrome is not known, and there is no cure, there are usually ways to help manage specific symptoms. The American College of Gastroenterology has resources for patients with Irritable bowel syndrome online at http://www.ibsrelief.org and free educational materials are available by calling ACG’s toll-free hotline 866-IBS-RELIEF.

http://www.acg.gi.org/

RELATED STORIES:
Crohn’s disease may respond to parasite therapy   Chewing gum after bowel surgery gets you out of hospital sooner   Promising new therapy for ulcerative colitis   Good bacteria may help against travelers’ diarrhea   Cognitive therapy improves irritable bowel syndrome   Bad hygiene blamed for typhoid in Russia, Ukraine   Researchers Identify Gene Variant Associated With Both Autism and Gastrointestinal Dysfunction   Link Between Gastric Bypass Surgery and Neurological Conditions   Nexium Can Reduce Stomach Ulcer in High Risk Patients   New Treatment for Bleeding Ulcers Reduces Surgery, Death Rates   Test spots acetaminophen-related liver toxicity   Diets high in fiber won’t protect against diverticulosis

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]